Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Cryotherapy in prostatic cancer].
Haug ES, Löffeler S, Urnes T. Haug ES, et al. Among authors: loffeler s. Tidsskr Nor Laegeforen. 2005 Oct 20;125(20):2835; author reply 2835-6. Tidsskr Nor Laegeforen. 2005. PMID: 16244700 Free article. Norwegian. No abstract available.
Tumour heterogeneity poses a significant challenge to cancer biomarker research.
Cyll K, Ersvær E, Vlatkovic L, Pradhan M, Kildal W, Avranden Kjær M, Kleppe A, Hveem TS, Carlsen B, Gill S, Löffeler S, Haug ES, Wæhre H, Sooriakumaran P, Danielsen HE. Cyll K, et al. Among authors: loffeler s. Br J Cancer. 2017 Jul 25;117(3):367-375. doi: 10.1038/bjc.2017.171. Epub 2017 Jun 15. Br J Cancer. 2017. PMID: 28618431 Free PMC article.
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P).
Löffeler S, Bertilsson H, Müller C, Aas K, Haugnes HS, Aksnessaether B, Pesonen M, Thon K, Tandstad T, Murtola T, Poulsen MH, Nordstrøm T, Vigmostad MN, Ottosson F, Holmsten K, Christiansen O, Slaaen M, Haug ES, Storås AH, Asphaug L, Rannikko A, Brasso K; Scandinavian Prostate Cancer Group (SPCG) and the Norwegian Get-Randomized (GRand) Initiative. Löffeler S, et al. BJU Int. 2024 Mar 12. doi: 10.1111/bju.16314. Online ahead of print. BJU Int. 2024. PMID: 38469686
Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol.
Siltari A, Riikonen J, Koskimäki J, Pakarainen T, Ettala O, Boström P, Seikkula H, Kotsar A, Tammela T, Helminen M, Raittinen PV, Lehtimäki T, Fode M, Østergren P, Borre M, Rannikko A, Marttila T, Salonen A, Ronkainen H, Löffeler S, Murtola TJ. Siltari A, et al. Among authors: loffeler s. BMJ Open. 2022 Apr 29;12(4):e050264. doi: 10.1136/bmjopen-2021-050264. BMJ Open. 2022. PMID: 35487730 Free PMC article.
16 results